线粒体DNA损伤与青光眼眼血流的关系
本研究纳入123例开角型青光眼患者和37例健康对照,用激光散斑血流图测视盘组织平均模糊率(MT)反映眼血流,用PCR测线粒体/核DNA比值(mtDNA/nDNA)反映线粒体功能障碍,发现重症男性患者中该比值与颞侧及上方MT显著相关。
要点
- 重症男性开角型青光眼患者中mtDNA/nDNA比值与颞侧MT(r=-0.46)及上方MT(r=-0.61)显著相关。
- 该比值在重症男性患者中是颞侧和上方MT的独立影响因素(p<0.01和p=0.03)。
- 整体开角型青光眼患者及女性患者中mtDNA/nDNA比值与MT无显著关系。
核心结论
- 重症男性开角型青光眼患者中mtDNA/nDNA比值与视盘组织平均模糊率存在显著关系,提示该比值可能成为青光眼新生物标志物。
研究设计与样本
- 横断面研究,纳入123例开角型青光眼患者的123只眼和37例健康对照者的37只眼。
- 用激光散斑血流图测视盘MT评估眼血流,用PCR测mtDNA和nDNA并计算mtDNA/nDNA比值。
- 用Spearman秩检验比较mtDNA/nDNA比值与MT,用多元回归分析重症组MT与青光眼的关系。
主要发现
- 对照组与青光眼组在mtDNA/nDNA比值、环视盘视网膜神经纤维层厚度和MT上均有显著差异。
- 整体开角型青光眼患者及女性患者中mtDNA/nDNA比值与MT无显著关系。
- 重症男性开角型青光眼患者中mtDNA/nDNA比值与MT(r=-0.46,p=0.03)、颞侧MT(r=-0.51,p=0.02)、上方MT(r=-0.61,p<0.01)显著相关。
- 重症男性患者中mtDNA/nDNA比值是颞侧MT(p<0.01)和上方MT(p=0.03)的独立影响因素。
临床怎么用
- 对重症男性开角型青光眼患者可考虑联合评估mtDNA/nDNA比值与视盘血流,辅助识别线粒体功能障碍易感者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIMS: We determined the relationship between tissue mean blur rate (MT) and mitochondrial dysfunction, represented by the mitochondrial/nuclear DNA (mtDNA/nDNA) ratio. We also investigated the usefulness of these biomarkers. METHODS: We assessed ocular blood flow in 123 eyes of 123 patients with open-angle glaucoma (OAG) and 37 control eyes of 37 healthy subjects by measuring MT in the optic nerve head with laser speckle flowgraphy. We measured mtDNA and nDNA with PCR, calculated the mtDNA/nDNA ratio and compared this ratio with MT using Spearman's rank test. We used multiple regression analysis to further investigate the association between MT and glaucoma in the most severe group. RESULTS: The control and the patients with glaucoma had significant differences in the mtDNA/nDNA ratio, circumpapillary retinal nerve fibre layer thickness and MT. There was no significant relationship between the mtDNA/nDNA ratio and MT in patients with OAG overall or the female patients with OAG, but there was a significant relationship between the mtDNA/nDNA ratio and MT, temporal-MT and superior-MT in male patients with severe OAG (r=-0.46, p=0.03; r=-0.51, p=0.02; r=-0.61, p<0.01, respectively). Furthermore, we found that the mtDNA/nDNA ratio was an independent contributor to temporal-MT and superior-MT in these patients (p<0.01 and p=0.03, respectively). CONCLUSION: We found that there was a significant relationship between the mtDNA/nDNA ratio and MT in male patients with severe OAG, suggesting that the mtDNA/nDNA ratio may be a new biomarker in glaucoma and may help research on the vulnerability of these patients to mitochondrial dysfunction.
引用
- Association between mitochondrial DNA damage and ocular blood flow in patients with glaucoma. Br J Ophthalmol. 2018. PMID: 30190366. doi:10.1136/bjophthalmol-2018-312356
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。